In one study, MSC-treated GVHD patients had a higher CD4+/CD8+ T cell ratio, increased frequency of Tregs, and higher levels of T cell receptor rearrangement excision circlets (TRECs), compared to pre-treatment and non-treated GVHD patients [113]. Here, CD4 is linked to graft versus host disease.